SeNostic Overview

  • Founded
  • 2016

  • Status
  • Private

  • Employees
  • 7

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

SeNostic General Information


Operator of a diagnostics company intended to provide a precise and accurate early differential diagnosis of multiple neurodegenerative disorders. The company provides biochemicals for neuroscience research and develops in Vitro diagnostic tests for neurodegenerative disorders as well as provides a unique way to amplify, and characterize disease-specific protein aggregates present in tissues and body fluids, enabling patients to avail themselves of proper treatment for their disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Feodor-Lynen-Straße 21
  • 30625 Hannover
  • Germany
+49 0511 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SeNostic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 29-May-2019 Completed Generating Revenue
2. Seed Round 25-Jan-2016 Completed Generating Revenue
1. Seed Round Completed Startup
To view SeNostic’s complete valuation and funding history, request access »

SeNostic Comparisons

HQ Location
Total Raised
Post Valuation
Operator of a diagnostics company intended to provide a precise and accurate early differential diagnosis of multiple ne
Hannover, Germany
7 As of 2022
0000000000 0


irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nul
0000 000000000
New York, NY
00 As of 0000
0000 0000-00-00
00000000000 00000

000 00

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
0000 000000000
Barcelona, Spain
00 As of 0000
00.00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SeNostic Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY 00 00000 00000000000 00000
000 000000000000 Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
000000000 000000 Venture Capital-Backed Burlington, MA 00 00000 0000000000 0 00000
0000000 000000 Venture Capital-Backed Stockholm, Sweden 00 000.00 0000000000 0 000.00
To view SeNostic’s complete competitors history, request access »

SeNostic Patents

SeNostic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4115976-A1 Reaction vessel Pending 05-Jul-2021 000000000 0
EP-3164716-A1 Process for diagnosis of neurodegenerative diseases Active 01-Jul-2014 00000000000
EP-3164716-B1 Process for diagnosis of neurodegenerative diseases Active 01-Jul-2014 00000000000
ES-2781104-T3 Procedure for the diagnosis of neurodegenerative diseases Active 01-Jul-2014 00000000000
US-20200309794-A1 Shear force generating device for analysis of biopsied mammalian samples Pending 01-Jul-2014 G01N33/6896
To view SeNostic’s complete patent history, request access »

SeNostic Executive Team (6)

Name Title Board Seat Contact Info
Thorsten Lührs Ph.D Co-Founder, Managing Director & Chief Executive Officer
Arne Ungruh Managing Director
Ingo Schlößin-Beneke Managing Director
Jörg Bode Managing Director
Klaus Nathusius Ph.D Advisor
You’re viewing 5 of 6 executive team members. Get the full list »

SeNostic Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SeNostic Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NBank Capital PE/Buyout Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg PE/Buyout Minority 000 0000 000000 0
To view SeNostic’s complete investors history, request access »